Rankings
▼
Calendar
PHAT Q3 2024 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$891M
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$16M
Gross Profit
$14M
85.6% margin
Operating Income
-$71M
-433.0% margin
Net Income
-$86M
-523.3% margin
EPS (Diluted)
$-1.32
QoQ Revenue Growth
+123.3%
Cash Flow
Operating Cash Flow
-$64M
Free Cash Flow
-$63M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$387M
Total Liabilities
$574M
Stockholders' Equity
-$187M
Cash & Equivalents
$335M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$0
—
Gross Profit
$14M
-$121,000
+11666.9%
Operating Income
-$71M
-$36M
-98.5%
Net Income
-$86M
-$43M
-97.9%
← FY 2024
All Quarters
Q4 2024 →